Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Fervo Energy secured two U.S. Department of Energy grants totaling approximately $20 million to accelerate the development of Enhanced Geothermal Systems (EGS) in Idaho and Nevada. The funding supports drilling, technology testing for high-temperature EGS operations, and appraisal campaigns to expand geothermal power capabilities in the western U.S…
Motorsport Games Inc. launched version 1.4.2 of their racing game Le Mans Ultimate, featuring a second U.S. Track Pack DLC with new tracks, updated 2026 racing liveries, and a preview of the redesigned RaceControl.gg platform. The update builds on the commercial success of V1.4, which saw strong engagement and record DLC launch revenues. The compan…
Nexxen, an advertising technology platform, has launched a new educational module titled 'Data for the Converged Media World' under its Nexxen U initiative. This module aims to help brands and media buyers understand complex data concepts related to converged media planning across linear TV, Connected TV, and digital video. Building on prior succes…
LPL Financial announced that Cornerstone Advisors and Clear Pointe Wealth Management, two well-established advisory teams managing approximately $1 billion in assets and previously with Northwestern Mutual, have joined LPL's broker-dealer, Registered Investment Advisor, and custodial platforms. The move is expected to support continued growth and e…
AIM ImmunoTech CEO Thomas Equels discusses Ampligen's unique immune-activating mechanism and clinical potential in pancreatic cancer treatment, emphasizing superior median overall survival in select patients compared to historical controls and the newly FDA-approved daraxonrasib. The company anticipates Ampligen's role both as a monotherapy and in …
Vicor's licensing of its VPD modules, a rapidly expanding backlog and improving margins create a compelling mid-term trade. Balance-sheet strength and low days-to-cover in short interest add a tactical tailwind. Entry $244.00, stop $210.00, target $320.00 over a 45-trading-day horizon.
MAIA Biotechnology reports significant progress in its Phase 3 THIO-104 clinical trial evaluating ateganosine, a novel telomere-targeting agent, for third-line treatment of advanced non-small cell lung cancer (NSCLC). The trial has enrolled 65 patients across multiple countries with expectations to exceed 100 by year-end. Early data shows a 90.5% d…
NVIDIA is trading around $227 with a trailing P/E near 28x despite revenue that doubled year-over-year and free cash flow north of $127B. This trade idea is a structured long: entry $227.25, stop $205.00, target $320.00, horizon 180 trading days. The bull case is still data-center-led revenue expansion, automotive DRIVE wins for trucks, and emergin…
Itron, Inc. announced a strategic collaboration with Crytica Security to integrate Crytica's Rapid Detection, Alert and Isolation (RDAi) technology into Itron's Grid Edge Intelligence platform. This partnership aims to provide utilities with enhanced cybersecurity by embedding real-time threat detection directly into grid-edge devices, improving de…
McDonald's (MCD) has pulled back to levels last seen at the September low, compressing valuation on a business still generating strong FCF and paying a near-3% yield. Technicals are oversold and short interest has ticked up, creating a set-up where a disciplined long—entered near the current price with a tight stop—offers asymmetric risk/reward ove…
OneMedNet Corporation has entered a multi-year strategic partnership with Atropos Health to embed OneMedNet's regulatory decision-grade, multimodal real-world data into Atropos's evidence-generation platform. This collaboration enhances data quality and accessibility for health systems, life sciences, and researchers, driving recurring revenue and …
Nvidia's combination of proprietary GPU architecture, software stack and cloud partnerships has created a moat that is hard for rivals to replicate. The company just reported another blowout quarter for AI data-center demand, has massive free cash flow and a market cap north of $5.5 trillion. This trade idea offers a disciplined long entry at $227.…
Palisade Bio announced FDA clearance of its Investigational New Drug application for PALI-2108, enabling initiation of a Phase 2 clinical trial (ASCENTRA-CD) in moderate to severe Crohn's disease. The trial targets approximately 60 patients, with first dosing anticipated in Q1 2027 and efficacy readout expected in Q1 2028. PALI-2108 is a novel oral…
MYR Group's pivot toward Commercial & Industrial (C&I) projects and recurring service revenues, plus two strategic acquisitions, helped deliver record Q2 revenues of $1.08B, an 88% jump in EPS, and a 170 bp gross margin expansion. With a $3.16B backlog and low leverage, the stock looks buyable around $288.56. This trade idea lays out an entry at $2…
Polyrizon Ltd., a clinical-stage biotech company listed on Nasdaq as PLRZ, has enrolled its first patient in a U.S. clinical study evaluating NASARIX (PL-14), a drug-free, intranasal hydrogel allergy blocker designed to reduce symptoms of seasonal allergic rhinitis. This milestone signifies the company's move into clinical development, aiming to of…
Idaho Copper Corporation received the U.S. Forest Service's approval for its Exploration Plan of Operations and 2026 annual operating plan, enabling the company to commence drilling activities at its CuMo copper-molybdenum-silver project in Boise County, Idaho. This clears the regulatory path after a decade of work and signals a transition toward a…
Lakeland Industries, Inc., through its independent service provider Colorado PPE, has opened a new facility in Centennial, Colorado. The facility offers comprehensive services for firefighter personal protective equipment (PPE) including cleaning, inspection, repair, rental, and NFPA 1850 training, aiming to exceed industry standards to better prot…
Vistagen announced positive preliminary data from the open-label extension portion of its PALISADE-4 Phase 3 study evaluating fasedienol for acute treatment of social anxiety disorder. The nasal spray was well-tolerated with no new safety issues during up to 12 months of as-needed use. Exploratory efficacy assessments showed clinically relevant imp…
Abercrombie & Fitch announced an expanded partnership with the Dallas Cowboys and Dallas Cowboys Cheerleaders, extending its role as the Official Fashion Partner for a second year. The collaboration introduces new product lines, year-round fan activations, athlete collaborations, and increased distribution through NFLShop and AT&T Stadium. The part…
Aprea Therapeutics announced that updated interim results from its Phase 1 trial of the WEE1 inhibitor APR-1051 in advanced solid tumors will be presented orally at the 38th EORTC-NCI-AACR Symposium. The data presentation highlights progress in their targeted cancer therapy pipeline, potentially impacting multiple tumor types including ovarian, col…
Zeo Energy Corp. has entered a cooperation agreement with Ewyze Corp. to jointly develop and commercialize integrated off-grid power microgrids combined with data-center infrastructure in the U.S. and selected international markets. This partnership addresses the growing demand for AI-capable, reliable, and scalable power solutions amid challenges …
Compass Therapeutics announced that the FDA recommended conducting an additional trial to prove a survival benefit for its drug tovecimig in advanced biliary tract cancer prior to Biologics License Application submission. Compass disagrees with the FDA's recommendation, citing positive Phase 2/3 trial results showing significant improvements in obj…
Quoin Pharmaceuticals announced the FDA granted Fast Track Designation for QRX003 to treat Peeling Skin Syndrome (PSS), a rare genetic skin disease with no approved therapies. This is the first Fast Track granted for PSS treatment and the second for QRX003, which also has Fast Track status for Netherton Syndrome. Following FDA clearance of the firs…
Grayscale Investments has introduced the Grayscale AI Compute ETF (GCPU), targeting companies involved in the physical infrastructure critical to AI's rapid expansion. The new fund tracks the Indxx High Performance Computing Index and provides exposure to firms building and transitioning operations toward AI workloads, reflecting a projected $1 tri…
Marchex, Inc. announces engagement with investor relations firm PondelWilkinson to support an expanded IR program aimed at increasing institutional investor awareness and supporting its growth strategy following the acquisition of Archenia. This acquisition broadens Marchex's capabilities in AI-driven customer acquisition and optimization, position…
